The sleep apnea devices market is on track for substantial growth, with a steady compound annual growth rate (CAGR) of 9.5% expected during the forecast period. In 2023, the market was valued at USD 8.2 billion and is anticipated to exceed USD 20.4 billion by 2033, highlighting its promising future.
The increasing prevalence of sleep apnea, combined with growing awareness of its health impacts, is driving demand for advanced sleep apnea devices worldwide. As healthcare providers and patients continue to prioritize better management of sleep disorders, innovations in device technology and treatment options will further fuel market expansion.
Key growth drivers include rising incidences of sleep apnea, particularly in aging populations, and the increasing adoption of home sleep testing devices. The market’s expansion is also supported by government initiatives aimed at enhancing healthcare accessibility, alongside technological advancements in non-invasive treatment methods.
Industry experts predict that the market’s growth will continue to accelerate as new products come to market, providing patients with more personalized and effective solutions for managing sleep apnea.
As the market grows, stakeholders across the healthcare and medical device sectors stand to benefit from the evolving landscape, contributing to improved patient outcomes and quality of life.
Key Takeaways:
- By type, therapeutic devices account for the majority of the market for sleep apnea devices owing to the increasing adoption of sleep apnea therapeutic devices and improving reimbursement scenarios for these devices.
- By end use, the home care settings segment is expected to grow at the fastest CAGR due to increasing patient and insurance company preference for home sleep testing, as well as a favourable reimbursement scenario for home sleep testing.
- Due to the rising prevalence of elderly people with chronic diseases such as diabetes and obesity, the geriatric segment is expected to dominate the sleep apnea devices market, thereby spiking the sales of sleep apnea devices.
- The direct tender segment is expected to dominate the global sleep apnea devices market since it provides high-quality and easily accessible sleep apnea devices to hospitals, diagnostic centers, ambulatory care centers, and specialty care centers.
- During the forecast period, Asia Pacific is expected to advance at a rapid pace and experience huge demand for sleep apnea devices on account rising elderly population and an increase in the prevalence of lifestyle illnesses.
“North America is projected to be at the forefront of the sleep apnea devices market due to the prevalence of expanding technological advancement in the region and major market players. On account of rising healthcare costs and well-established healthcare infrastructure, the obstructive sleep apnea syndrome segment in the United States of North America is expected to hold a large sleep apnea devices market share.” says an FMI analyst.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!
Competitive Landscape:
The major sleep apnea devices market companies providing sleep apnea devices are ResMed, Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO., LTD, Koninklijke Philips N.V., BMC Medical Co., Ltd., SomnoMed, Medicom MTD Ltd, Somnowell, Fisher & Paykel Healthcare Limited Compumedics Limited.
Many product launches and agreements are also being initiated by companies around the world, which is accelerating the sleep apnea devices market opportunities.
Collaboration, award and recognition, business expansion, and joint ventures are enhancing the company market in the sleep apnea devices market, which also augurs well for the sleep apnea devices market future trends.
Some of the recent developments in the sleep apnea devices market are:
- Cleveland Medical Devices Inc. has announced that the company’s SleepView Direct service has been recognized in an article published in Sleep Review Magazine. This improved the company’s product’s ability to reach a large number of customers worldwide.
- Oventus Medical has entered into a partnership agreement with Aeroflow Healthcare to bring Oventus’ obstructive sleep apnea (OSA) treatment solutions, including O2Vent Optima, directly to consumers in the United States through sleep clinics.
Key Segments:
By Product:
- Therapeutics
- Airway Clearance Systems
- Adaptive Servo-ventilation (ASV)
- Positive Airway Pressure (PAP) Device
- Oral Appliances
- Oxygen Devices
- Others
- Diagnostics
- Actigraphy Systems
- Polysomnography (PSG) Device
- Respiratory Polygraph
- Sleep Screening Devices
By End User:
- Home Care Settings & Individuals
- Sleep Laboratories & Hospitals
By Region:
- North America
- Latin America
- Europe
- Asia Pacific (APAC)
- The Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube